Nanoscale and fine zinc oxide particles: can in vitro assays accurately forecast lung hazards following inhalation exposures?
about
New perspectives for in vitro risk assessment of multiwalled carbon nanotubes: application of coculture and bioinformaticsMulti-walled carbon nanotubes induce human microvascular endothelial cellular effects in an alveolar-capillary co-culture with small airway epithelial cellsAt the Crossroads of Nanotoxicology in vitro: Past Achievements and Current ChallengesMicrovascular and mitochondrial dysfunction in the female F1 generation after gestational TiO2 nanoparticle exposure.Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testingAn integrated approach for the in vitro dosimetry of engineered nanomaterialsSurface modification of zinc oxide nanoparticles with amorphous silica alters their fate in the circulationSynergistic effect of bolus exposure to zinc oxide nanoparticles on bleomycin-induced secretion of pro-fibrotic cytokines without lasting fibrotic changes in murine lungsEngineered nanomaterials: exposures, hazards, and risk preventionEngineering safer-by-design, transparent, silica-coated ZnO nanorods with reduced DNA damage potentialA review of mammalian toxicity of ZnO nanoparticlesTranscriptomic analysis reveals novel mechanistic insight into murine biological responses to multi-walled carbon nanotubes in lungs and cultured lung epithelial cellsUse of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammationIntracellular accumulation dynamics and fate of zinc ions in alveolar epithelial cells exposed to airborne ZnO nanoparticles at the air-liquid interfaceUse of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterialsAerosolized ZnO nanoparticles induce toxicity in alveolar type II epithelial cells at the air-liquid interfaceBioavailability, distribution and clearance of tracheally-instilled and gavaged uncoated or silica-coated zinc oxide nanoparticlesEmergent Properties and Toxicological Considerations for Nanohybrid Materials in Aquatic SystemsISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studiesCytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays.Feasibility of biomarker studies for engineered nanoparticles: what can be learned from air pollution researchProgressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes.Informing selection of nanomaterial concentrations for ToxCast in vitro testing based on occupational exposure potentialCytotoxic effects of ZnO hierarchical architectures on RSC96 Schwann cells.Nanosized zinc oxide particles do not promote DHPN-induced lung carcinogenesis but cause reversible epithelial hyperplasia of terminal bronchioles.In vitro and in vivo testing methods for respiratory drug delivery.Advances in pulmonary delivery of nanoparticles.A critical review of in vitro dosimetry for engineered nanomaterials.Continuous in vitro exposure of intestinal epithelial cells to E171 food additive causes oxidative stress, inducing oxidation of DNA bases but no endoplasmic reticulum stress.The toxicology of ion-shedding zinc oxide nanoparticles.Risk assessment of zinc oxide, a cosmetic ingredient used as a UV filter of sunscreens.Methodological considerations when conducting in vitro, air-liquid interface exposures to engineered nanoparticle aerosols.Particulate nature of inhaled zinc oxide nanoparticles determines systemic effects and mechanisms of pulmonary inflammation in mice.A pilot study on neopterin levels and tryptophan degradation in zinc-exposed galvanization workers.Comparison of dose-response relations between 4-week inhalation and intratracheal instillation of NiO nanoparticles using polimorphonuclear neutrophils in bronchoalveolar lavage fluid as a biomarker of pulmonary inflammation.Interaction of PM2.5 airborne particulates with ZnO and TiO2 nanoparticles and their effect on bacteria.Involvement of the cytokine-IDO1-AhR loop in zinc oxide nanoparticle-induced acute pulmonary inflammation.Adoption of in vitro systems and zebrafish embryos as alternative models for reducing rodent use in assessments of immunological and oxidative stress responses to nanomaterials.NMR-based metabolomics to determine acute inhalation effects of nano- and fine-sized ZnO particles in the rat lung.Nano zerovalent iron particles induce pulmonary and cardiovascular toxicity in an in vitro human co-culture model.
P2860
Q23910479-1B4FE1F4-F300-4A5C-A6B5-F49BC922CDF6Q23910481-2DB9730D-01D6-49C9-BCD0-F4EA5860A17AQ26796677-5D5594E1-1A11-4F06-B61B-611B15F62AB3Q27334474-D13F58B8-F611-4C04-ABDF-1E2B22E26531Q28385263-74B5A381-D078-4BA2-AE37-6789EC5B154CQ28386114-9DF96746-341E-4E01-9455-8E5B6163F725Q28386316-49C53062-DF80-4654-9705-8036C5F616FEQ28386689-2D4CB09C-8818-4079-9F05-40549ADE6C93Q28387517-E62D9CBB-2A69-4BF4-8DEA-8A1D803CF225Q28388100-44167934-7811-486A-9928-BBB1200B8B85Q28389049-46662DF5-BF4F-41D8-9942-3353CBA3BBE6Q28391236-BFF38E93-AE1E-4857-86B5-8D0A064AF3FCQ28392757-CED25C5F-D071-4FCA-B061-4E58245C7192Q28394270-088B7ED9-C112-41EA-9B13-554D830C28D1Q28394548-82B0C84F-99B3-452E-9BED-0D5E85E8C3AFQ28395846-415D0C58-FCF3-4E3D-AA92-21C2A142F215Q28397883-961E817E-BE52-4F6D-9736-1C4F81C89F8AQ29248320-BA562B38-CE98-4CDF-9765-4A382D6B7261Q34451016-04F68F20-5DC3-4F2D-B017-68BEB1424A2CQ34686914-9E7319C5-23B3-43D7-82D8-A5C54B2540EEQ35185061-9EBB0F25-E51B-4C50-96E5-BA7978C5ECFBQ35230361-DA24CC20-5FAE-4B51-AD16-A0E7030844C9Q35579934-F9FA6623-9B2F-497F-B263-178D6D1868E6Q36209638-9ECAA84E-4DCA-4D55-A348-85879BC7F9D7Q37470705-FDBB6118-3DBB-407E-95E0-4C374A149DBAQ37822755-C8FC5A41-1340-410D-A79D-916826290582Q37909465-9A55CA02-BF61-48FC-B3A9-A08B0EA29945Q38595356-12CAAF40-A78C-46B6-90EE-1EEF5BF8D28EQ38697184-9948FED0-ADC3-4C32-9667-1F9293C9EA6CQ38768649-B36CA142-43C7-4469-BB85-81C756DB589CQ38783310-DA13AE9E-C171-4788-8BFE-459F59857210Q38819505-6761B3A6-F43D-4CA6-9529-407CE80988EAQ39021861-077B1EC1-DA58-46A1-8999-F28FB77D92E0Q44292102-03B496FC-F7D8-4C7E-90CD-61005252623FQ44672180-0DF218B9-28D9-4825-90A7-A69C3AA494ECQ47746418-E974AE79-1719-4C7A-AFAF-1B7D1D6D10E0Q47951534-34D66F04-3879-4491-B36C-5EE85A61B4CDQ48119346-4FFBF6F5-5CA8-4786-B4B1-45CDAA693C29Q51515278-074A3C05-EA69-4315-A7AB-5198ECCC0CE6Q51596330-73D6AB80-8213-449D-820A-963635685E3A
P2860
Nanoscale and fine zinc oxide particles: can in vitro assays accurately forecast lung hazards following inhalation exposures?
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Nanoscale and fine zinc oxide ...... ollowing inhalation exposures?
@en
Nanoscale and fine zinc oxide ...... ollowing inhalation exposures?
@nl
type
label
Nanoscale and fine zinc oxide ...... ollowing inhalation exposures?
@en
Nanoscale and fine zinc oxide ...... ollowing inhalation exposures?
@nl
prefLabel
Nanoscale and fine zinc oxide ...... ollowing inhalation exposures?
@en
Nanoscale and fine zinc oxide ...... ollowing inhalation exposures?
@nl
P356
P1476
Nanoscale and fine zinc oxide ...... ollowing inhalation exposures?
@en
P2093
P304
P356
10.1021/ES901453P
P407
P577
2009-10-01T00:00:00Z